International Patent: COMPOUNDS AND METHODS FOR SKIPPING EXON 51 IN DUCHENNE MUSCULAR DYSTROPHY

GENEVA, July 18 -- ENTRADA THERAPEUTICS, INC. filed a patent application (US2026/010732) for “COMPOUNDS AND METHODS FOR SKIPPING EXON 51 IN DUCHENNE MUSCULAR DYSTROPHY”. With publication no. WO/2026/151958, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 47/64

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....